Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Nuformix (NFX)

Price 0.0725p on 05-02-2025 at 15:35:20
Change -0.0025p -3.33%
Buy 0.075p
Sell 0.07p
Buy / Sell NFX Shares
Last Trade: Sell 125,301.00 at 0.0711p
Day's Volume: 42,691,316
Last Close: 0.075p
Open: 0.075p
ISIN: GB00BYW79Y38
Day's Range 0.065p - 0.075p
52wk Range: 0.04p - 0.30p
Market Capitalisation: £1m
VWAP: 0.070204p
Shares in Issue: 1,419m

Recent Trades History Nuformix (NFX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 125,301 0.0711p Ordinary
15:35:18 - 05-Feb-25
Sell* 5,960 0.0711p Ordinary
15:24:48 - 05-Feb-25
Buy* 13,146 0.075p Ordinary
15:20:29 - 05-Feb-25
Buy* 16,666 0.075p Ordinary
15:18:49 - 05-Feb-25
Buy* 253 0.075p Ordinary
15:17:49 - 05-Feb-25
Buy* 2,500,000 0.07p Ordinary
15:11:15 - 05-Feb-25
Buy* 547,257 0.07p Ordinary
15:08:55 - 05-Feb-25
Buy* 4,970,859 0.0693p Ordinary
15:04:54 - 05-Feb-25
Buy* 24,114 0.07p Ordinary
15:00:13 - 05-Feb-25
Buy* 29,657 0.07p Ordinary
14:57:43 - 05-Feb-25

Share Price History for Nuformix

Time period:
to
Date Open High Low Close Volume

Share News for Nuformix

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

29th Jan 2025 15:48

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal

13th Jan 2025 12:50

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

28th Oct 2024 12:27

Read More

IN BRIEF: Nuformix shares fall despite interim loss narrowing

18th Jun 2024 18:37

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ended March 31, unchanged from a year earlier. Pretax loss narrows to GBP242,529 from GBP337,622. Read More

Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment

17th Jun 2024 10:37

(Alliance News) - Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further protections for its fibrosis and oncology technology. Read More

FTSE 100 Latest
Value8,604.58
Change33.81

Login to your account

Forgot Password?

Not Registered